Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hanni Uusi-Kerttula

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Oncotarget|November 28, 2018
Precision virotherapies: Coming soonHanni Uusi-Kerttula, Alan L Parker
The Journal of Infectious Diseases|June 28, 2014
High serum levels of norovirus genotype-specific blocking antibodies correlate with protection from infection in childrenMaria Malm, Hanni Uusi-Kerttula, Timo Vesikari, et al.
Microbes and Infection|March 18, 2014
Comparison of human saliva and synthetic histo-blood group antigens usage as ligands in norovirus-like particle binding and blocking assaysHanni Uusi-Kerttula, Kirsi Tamminen, Maria Malm, et al.
Viruses|November 28, 2015
Oncolytic Adenovirus: Strategies and Insights for Vector Design and Immuno-Oncolytic ApplicationsHanni Uusi-Kerttula, Sarah Hulin-Curtis, James Davies, et al.
Clinical and Vaccine Immunology : CVI|April 24, 2015
Genotype considerations for virus-like particle-based bivalent norovirus vaccine compositionMaria Malm, Kirsi Tamminen, Suvi Lappalainen, et al.
Human Gene Therapy|March 13, 2014
Retargeting adenovirus serotype 48 fiber knob domain by peptide incorporationLynda Coughlan, Hanni Uusi-Kerttula, Jiangtao Ma, et al.
Oncotarget|April 9, 2016
Pseudotyped αvβ6 integrin-targeted adenovirus vectors for ovarian cancer therapiesHanni Uusi-Kerttula, James Davies, Lynda Coughlan, et al.
Human Gene Therapy|April 29, 2015
Incorporation of Peptides Targeting EGFR and FGFR1 into the Adenoviral Fiber Knob Domain and Their Evaluation as Targeted Cancer TherapiesHanni Uusi-Kerttula, Mateusz Legut, James Davies, et al.
Nature Communications|February 16, 2019
Diversity within the adenovirus fiber knob hypervariable loops influences primary receptor interactionsAlexander T Baker, Alexander Greenshields-Watson, Lynda Coughlan, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|July 15, 2015
His-tagged norovirus-like particles: A versatile platform for cellular delivery and surface displayTiia Koho, Teemu O Ihalainen, Marie Stark, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Oncotarget|November 28, 2018
Precision virotherapies: Coming soonHanni Uusi-Kerttula, Alan L Parker
The Journal of Infectious Diseases|June 28, 2014
High serum levels of norovirus genotype-specific blocking antibodies correlate with protection from infection in childrenMaria Malm, Hanni Uusi-Kerttula, Timo Vesikari, et al.
Microbes and Infection|March 18, 2014
Comparison of human saliva and synthetic histo-blood group antigens usage as ligands in norovirus-like particle binding and blocking assaysHanni Uusi-Kerttula, Kirsi Tamminen, Maria Malm, et al.
Viruses|November 28, 2015
Oncolytic Adenovirus: Strategies and Insights for Vector Design and Immuno-Oncolytic ApplicationsHanni Uusi-Kerttula, Sarah Hulin-Curtis, James Davies, et al.
Clinical and Vaccine Immunology : CVI|April 24, 2015
Genotype considerations for virus-like particle-based bivalent norovirus vaccine compositionMaria Malm, Kirsi Tamminen, Suvi Lappalainen, et al.
Human Gene Therapy|March 13, 2014
Retargeting adenovirus serotype 48 fiber knob domain by peptide incorporationLynda Coughlan, Hanni Uusi-Kerttula, Jiangtao Ma, et al.
Oncotarget|April 9, 2016
Pseudotyped αvβ6 integrin-targeted adenovirus vectors for ovarian cancer therapiesHanni Uusi-Kerttula, James Davies, Lynda Coughlan, et al.
Human Gene Therapy|April 29, 2015
Incorporation of Peptides Targeting EGFR and FGFR1 into the Adenoviral Fiber Knob Domain and Their Evaluation as Targeted Cancer TherapiesHanni Uusi-Kerttula, Mateusz Legut, James Davies, et al.
Nature Communications|February 16, 2019
Diversity within the adenovirus fiber knob hypervariable loops influences primary receptor interactionsAlexander T Baker, Alexander Greenshields-Watson, Lynda Coughlan, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|July 15, 2015
His-tagged norovirus-like particles: A versatile platform for cellular delivery and surface displayTiia Koho, Teemu O Ihalainen, Marie Stark, et al.
Pageof 2